Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01492192
What this trial is testing

RGD-PET-CT in Cancer Angiogenesis

Who this might be right for
Carcinoma, Renal Cell
Oxford University Hospitals NHS Trust 10
Testing effectiveness (Phase 2)UnknownNCT00795171
What this trial is testing

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Medical University of Vienna 60
Large-scale testing (Phase 3)Study completedNCT00346437
What this trial is testing

Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3)

Who this might be right for
Angina Pectoris
Cardium Therapeutics 416
Not applicableNot Yet RecruitingNCT07324681
What this trial is testing

Evaluation of Irisin Levels in Adult Forearm Fracture Surgery Under Infraclavicular Block and General Anesthesia

Who this might be right for
InflamationHealingAngiogenesis
Ankara City Hospital Bilkent 90
Early research (Phase 1)Study completedNCT02619383
What this trial is testing

HBOT Application in Erectile Dysfunction

Who this might be right for
Erectile DysfunctionHyperbaric Oxygen Therapy
Assaf-Harofeh Medical Center 37
Early research (Phase 1)Study completedNCT00203203
What this trial is testing

Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)

Who this might be right for
Ischemic Cardiomyopathy
Texas Heart Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT01356290
What this trial is testing

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Who this might be right for
Medulloblastoma RecurrentEpendymoma RecurrentATRT Recurrent+1 more
Medical University of Vienna 232
Testing effectiveness (Phase 2)Study completedNCT01351025
What this trial is testing

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 98
Testing effectiveness (Phase 2)Ended earlyNCT00684996
What this trial is testing

Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerRenal Cell CarcinomaStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 5
Not applicableNot Yet RecruitingNCT06620068
What this trial is testing

Causal Relationship Between Plasma VEGF Family Proteins and Placenta Previa: A Two-Sample Mendelian Randomization Study

Who this might be right for
Placenta Previa
Guangzhou Institute of Respiratory Disease 207,473
Not applicableEnded earlyNCT01049919
What this trial is testing

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

Who this might be right for
Critical Limb IschemiaPeripheral Arterial DiseasePeripheral Vascular Disease
Zimmer Biomet 153
Not applicableStudy completedNCT00828919
What this trial is testing

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

Who this might be right for
Solid Tumors
Pfizer 52
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT04055792
What this trial is testing

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

Who this might be right for
Extensive Disease Small Cell Lung Cancer
Henan Cancer Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00083694
What this trial is testing

Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia

Who this might be right for
Leukemia
University of Arkansas 25
Not applicableStudy completedNCT05485467
What this trial is testing

The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients

Who this might be right for
VasculopathyHeart Transplant Failure
University Medical Centre Ljubljana 55
Testing effectiveness (Phase 2)UnknownNCT00383851
What this trial is testing

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Who this might be right for
Melanoma
Attenuon 60
Testing effectiveness (Phase 2)WithdrawnNCT00244920
What this trial is testing

Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00284141
What this trial is testing

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Who this might be right for
Pulmonary DiseasesNeoplasms, Lung
Sanofi 98
Early research (Phase 1)Study completedNCT00001683
What this trial is testing

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Who this might be right for
LymphomaMelanomaNeoplasm Metastasis+1 more
National Cancer Institute (NCI) 35
Next Page